Try our Advanced Search for more refined results
In Re: Zofran (Ondansetron)Products Liability Litigation
Case Number:
1:15-md-02657
Court:
Nature of Suit:
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability
Multi Party Litigation:
Multi-district Litigation
Judge:
Firms
- Saunders & Walker
- Searcy Denney
- Seeger Weiss
- O'Leary Shelton
- Holland & Hart
- Edwards & Culver
- Phillips Lytle
- Wagstaff Law Firm
- Langdon & Emison
- Ventura Law (Danbury, CT)
- Peiffer Wolf
- Parker Waichman
- The Myers Firm
- Silva & Silva PA
- Paul Knopf
- Maynard Nexsen
- Hissey Mulderig
- Ashcraft & Gerel
- Snow Legal Group
- Gathings Law
- Maher Law Firm
- The Flood Law Firm
- Levin Simes
- Goldman Scarlato
- Silva & Silva
- Kershaw Talley
- Meyers & Flowers
- Reiner Slaughter
- Harness IP
- Cohen & Malad
- Pogust Goodhead
- Lear Werts
- Ware Jackson Lee
- Dunn Sheehan
- Donnelly Conroy
- Murray Law Firm
- Skikos Crawford
- Gurfein Douglas
- Nabers Law Firm
- Bailey & Greer
- Curtis Law Group
- Zoll & Kranz
- Baron & Budd
- Harrelson Law Firm
- Rheingold Giuffra
- Beasley Allen
- Heninger Garrison
- Bednarz & Bednarz
- Belt & Bruner
- Williams & Connolly
- Bernstein Liebhard
- Helland Law Firm
- Kiernan Trebach
- Helmsdale Law LLP
- Herman Herman & Katz
- Bird Law Group
- Justinian & Associates
- Power Rogers
- Cowper Law
- Lieff Cabraser
- Motley Rice
- Jackson & Tucker
- Bisnar Chase
- DiCello Levitt
- Bizer & DeReus
- Becker Law Office
- Arnold & Porter
- Nixon Peabody
- Tucker Ellis
- Pittman Dutton
- Engstrom Lipscomb
- Anapol Weiss
- Smith Porsborg
- Schlesinger Law Offices
- Feldman Shepherd
- Reich & Binstock
- BrownGreer PLC
- Michael Brady Lynch Firm
- Remer & Georges-Pierre
- Flint Cooper
- Napoli Shkolnik
- Robins Kaplan
- TorHoerman Law
- Sherman Silverstein
- Dowdy Cockerham
- eDiscovery CoCounsel
- Simmons Hanly
- Quattlebaum Grooms
- OnderLaw
- Eichen Crutchlow
- Morrow Morrow
- Thomas & Libowitz
- Blizzard Greenberg
- Brisbee & Stockton
- Rudolph Friedmann
- Bruera Law Firm
- Wagstaff & Cartmell
- Buxbaum Daue
- Kreindler & Kreindler
- Kelley Uustal
- Van Wey Presby
- Greenberg Traurig
- Shook Hardy
- Irwin Fritchie
- Junell & Associates
- Kagan Law Firm
- Kelley & Ferraro
- Kenny & Kenny
- George & Farinas
- Hare Wynn
- Ashley Injury Lawyers
- O'Hara Law Firm
- Jenner Law
- Goede DeBoest
- Grant & Eisenhofer
- Haug Partners
- Law Offices of Arnold E. DiJoseph
Companies
Sectors & Industries:
-
March 01, 2024
GSK, Shook Hardy Can Recover Costs After Zofran MDL Win
GlaxoSmithKline and its attorneys from Shook Hardy & Bacon LLP can recover more than $450,000 in legal costs after beating a multidistrict suit claiming the company's anti-nausea drug Zofran caused birth defects, a federal judge has ruled.
-
March 16, 2023
Families In GSK MDL Rip Shook Hardy For 'Ironic' Costs Bid
Families that sued GlaxoSmithKline claiming its anti-nausea drug Zofran caused birth defects told a federal judge Wednesday that the company can't recoup roughly $578,000 in costs and called it "ironic" and "disheartening" because GSK's firm, Shook Hardy & Bacon LLP, had dropped a similar request in another multidistrict litigation.
-
June 25, 2021
Top Product Liability Cases Of 2021: Midyear Report
A U.S. Supreme Court ruling holding that Ford can be held liable for alleged defects in cars originally sold outside a plaintiff's home state and a ruling wiping out hundreds of cases alleging GlaxoSmithKline's anti-nausea drug Zofran causes birth defects are among Law360's top cases for the first six months of 2021.
-
June 18, 2021
GSK Gets Top Court Assist In MDL Victory 'Roadmap'
A sweeping order ending more than 400 cases alleging GlaxoSmithKline's anti-nausea medication Zofran causes birth defects provides a "roadmap" for fending off multidistrict litigation with the help of a landmark U.S. Supreme Court ruling, experts say.
-
June 01, 2021
Key Ruling Foils GSK Zofran MDL Ahead Of Bellwether
GlaxoSmithKline will not have to face more than 420 suits in multidistrict litigation alleging its anti-nausea medication Zofran causes birth defects, after a Massachusetts federal judge ruled Tuesday the claims are preempted because federal regulators declined to add a warning label for pregnant women.
-
April 21, 2021
Possible 'Showstopper' Ruling Looms In GSK Birth Defect Suit
A federal judge said during a Wednesday hearing that a ruling on whether claims that GlaxoSmithKline's anti-nausea medication Zofran triggers birth defects are preempted will be coming soon, a decision he's called a potential "showstopper" in the multidistrict suit.
-
March 24, 2021
GSK Says No Link Between Zofran, Defects Undermines MDL
Lawyers for GlaxoSmithKline argued Wednesday that more than 300 cases in a multidistrict product liability suit over its anti-nausea medication should be nixed since the plaintiffs' own expert determined there is no link between the drug and cardiac birth defects.
-
February 24, 2021
Zofran Birth Defect MDL Finally Heading For Trial In Fall
A Massachusetts federal judge running the first bellwether in multidistrict litigation over whether GlaxoSmithKline's anti-nausea medication Zofran causes birth defects said Wednesday that he's considering an October starting date after a lengthy postponement triggered by the coronavirus pandemic.
-
November 10, 2020
GSK Says FDA Rejected Zofran Label Change
GlaxoSmithKline on Monday told a Massachusetts federal judge overseeing multidistrict litigation over its anti-nausea medicine Zofran that the U.S. Food and Drug Administration has rejected a proposed label change that would have added birth defect warnings.
-
June 23, 2020
Pandemic May Push 1st Zofran MDL Bellwether To 2021
A Massachusetts federal judge told lawyers representing GlaxoSmithKline and plaintiffs who claim its anti-nausea medicine Zofran caused birth defects that he's open to creative ways to hold a complex jury trial with social distancing, but he may have no choice but to wait until 2021.